Publicaciones internacionales
Aquí le ofrecemos una selección de publicaciones científicas relacionadas con la inmunoterapia IOZK.
Puede utilizar los filtros para hacer una selección según tipos de tumores y métodos, o introducir términos de búsqueda.
A low selenium level is associated with lung and laryngeal cancers
Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity
Harnessing the immune system for the treatment of non-small-cell lung cancer
Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future
Current status of immunotherapy for the treatment of biliary tract cancer
Vaccine strategies for glioblastoma: progress and future directions
Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy
Oncolytic virus therapy for cancer: the first wave of translational clinical trials
Curcumin in various cancers
Molecular mechanisms of curcumin action: signal transduction
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
Oncothermia: a new paradigm and promising method in cancer therapies
A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses
Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel